ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Energy Status of Pig Donor Organs after Ischemia Is Independent of Donor Type

    M. Sereinigg, A. Puntschart, V. Stadlbauer, F. Iberer, B. Leber, K. Tscheliessnigg, G. Jürgens, T. Sefert-Held, S. Hallström, P. Stiegler

    Department of Transplantation Surgery, Medical University Graz, Graz, Austria; Department of Gastroenterology and Hepatology, Medical University Graz, Graz, Austria; Institute of Physiological Chemistry, Medical University Graz, Graz, Austria; Department of Neurology, Medical University Graz, Graz, Austria

    Background. Literature is controversial whether organs from living donors have a better graft function than brain dead and non-heart-beating donor organs. Success of transplantation has…
  • 2013 American Transplant Congress

    Organ Function Preservation by the Combination Treatment of the OptImuM Dose of CalcineUrin Inhibitor and Mycophenolate Sodium in Kidney Recipients: OPTIMUM Study

    S. Park, J. Lee, Y. Kim, J. Kim, Y. Kim, W. Huh, C. Yang, Y. Kim

    Internal Medicine, Seoul National University School of Medicine, Seoul, Korea; Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea; Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea; Internal Medicine, BongSeng Hospital, Busan, Korea; Internal Medicine, Inje University, College of Medicine, Busan, Korea; Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Transplantation Research Center, Seoul St. Mary's Hospital, Seoul, Korea; Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea

    Background. Introduction of the calcineurine inhibitors has significantly increased 1-year renal allograft survival, however, they have not extended long-term allograft survival. Here, we have hypothesized…
  • 2013 American Transplant Congress

    Obesity and Liver Transplant Outcomes

    N. Kemmer, G. Neff, E. Cece, E. Parkinson, A. Alsina

    Division of Liver Transplantation, Tampa General Medical Group, Tampa, FL

    With the rising prevalence of obesity in the US, the proportion of liver transplant (LT) candidates who are obese (BMI >30) is expected to increase.…
  • 2013 American Transplant Congress

    miRNA in Urinary Pellet Samples of Kidney Transplant Recipients as Diagnostic and Predictive Markers of Progression to Chronic Allograft Dysfunction

    J. Suh, D. Maluf, R. Gehrau, K. Brayman, V. Mas

    UVA, Charlottesville

    Background: A major obstacle in the management of kidney transplant recipients is a lack of non-invasive, cost-effective, specific biomarkers critically needed for monitoring graft performance…
  • 2013 American Transplant Congress

    Preformed HLA Donor Specific Alloantibodies in African-Americans Increases Their Risk of Death after Liver Transplant

    J. O'Leary, H. Kaneku, L. Jennings, B. Susskind, P. Terasaki, G. Klintmalm

    Annette C & Harold C Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX; Terasaki Foundation Laboratory, Los Angeles, CA

    Aim: African American (AA) patients who receive Caucasian (CA) liver allografts have an increased risk of death compared to AA patients who receive AA liver…
  • 2013 American Transplant Congress

    How To Estimate Kidney Function in Kidney Transplant Recipients with Mild to Moderate Kidney Impairment. – Comparison of eGFR Values between Creatinine-Based GFR Equation and Cystatin C-Based Equation for Japanese

    M. Tsujita

    Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan

    [Background] Recently the number of renal transplantation has increased in Japan. To know how to assess renal function accurately for Japanese renal transplant recipients is…
  • 2013 American Transplant Congress

    Elderly Patients with Cronic Renal Disease: Do They Deserve a Renal Transplant?

    P. Orlandi, M. Cristelli, C. Rodrigues, C. Felipe, H. Tedesco, J. Medina-Pestana

    Hospital do Rim e Hipertensão, São Paulo, Brazil; Nephrology, Escola Paulista de Medicina, São Paulo, Brazil

    The number of elderly patients with chronic renal failure is increasing as the population ages. Kidney transplantation is a growing therapeutic option for this population.…
  • 2013 American Transplant Congress

    Characterization of Different Gene Families Encoding for Pro-Apoptotic and Anti-Apoptotic as Well as Genes Encoding for Oxidative Stress Induced Cell Damage in Organ Donation: An Animal Study

    P. Stiegler, M. Sereinigg, A. Puntschart, A. Bradatsch, S. Stanzer, E. Stdelmeyer, I. Wiederstein-Grasser, F. Iberer, K. Tscheliessnigg, V. Stadlbauer

    Department for Transplantation Surgery, Medical University Graz, Graz, Austria; Department for Gastroenterology and Hepatology, Medical University Graz, Graz, Austria; Department for Oncology, Medical University Graz, Graz, Austria; Division of Biomedical Research and Section for Surgical Research, Medical University Graz, Graz, Austria

    Literature is controversial about the influence of different gene families on the quality of organs after brain death as compared to living donation. In this…
  • 2013 American Transplant Congress

    Alemtuzumab Induction in Simultaneous Pancreas and Kidney Transplantation

    M. Zachariah, A. Gregg, J. Schold, J. Magliocca, L. Kayler

    Nephrology and Transplantation, SUNY at Buffalo, Buffalo, NY; Department of Medicine, University of Florida, Gainesville, FL; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH; Department of Surgery and Transplantation, Emory University, Atlanta, GA; Department of Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY

    Background: Alemtuzumab is a monoclonal anti-CD52 antibody used as an induction agent in organ transplantation. Few studies have analyzed this agent in the context of…
  • 2013 American Transplant Congress

    Dynamic Composite Analyses Identify Biomarkers of Progression to Chronic Allograft Dysfunction after Kidney Transplantation

    V. Mas, J. Suh, J. Lee, R. Gehrau, K. Brayman, N. Mehta, D. Maluf

    UVA, Charlottesville

    Background. Loss of kidney graft function due to interstitial fibrosis (IF) and tubular atrophy (TA) remains the main clinical challenge for long-term graft survival rate.Methods.…
  • « Previous Page
  • 1
  • …
  • 56
  • 57
  • 58
  • 59
  • 60
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences